港股異動 | 平安好醫生(1833.HK)漲5.78% 刷新歷史新高
格隆匯2月16日丨平安好醫生(1833.HK)高開,現漲5.78%,報135.4港元,盤初高見138.7港元創歷史新高,最新總市值1553億港元。消息面上,2月10日,ARKF基金新建倉平安好醫生,買入49.78萬股,佔比為0.1854%。此前,平安好醫生公佈2020年業績,實現收入約人民幣68.66億元,同比增長35.5%;毛利約18.64億元,同比增長59.2%;毛利率為 27.2%,較2019年的毛利率23.1%提升了4.1個百分點。此前花旗發研報指,花旗維持平安好醫生“買入”評級,目標價130港元。富瑞則給予平安好醫生目標價211港元,買入評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.